News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Mary Grace Johnson

Articles by Mary Grace Johnson

6 Real-world Adherence and Persistence With Palbociclib Treatment Among Insured Patients With HR+/HER2– Metastatic Breast Cancer in the United States

ByNicole M. Engel-Nitz,Samantha M. Kurosky, Mary Grace Johnson,Michael P. Johnson,Xianchen Liu

April 18th 2022

Latest Updated Articles

6 Real-world Adherence and Persistence With Palbociclib Treatment Among Insured Patients With HR+/HER2– Metastatic Breast Cancer in the United States
Published: April 18th 2022 | Updated:

Trending on CancerNetwork

Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC

FDA Accepts NDA for Rivoceranib and Camrelizumab in 1L Unresectable HCC

TLD-1433 Exhibits Early Efficacy in BCG-Unresponsive NMIBC CIS

FDA Accepts NDA for Zanzalintinib/Atezolizumab in Pretreated Metastatic CRC

Modifiable Risk Factors Suggest Potential for Improving Cancer Prevention